ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

December 2, 1983

Stop Cancer Still Working To Raise Funds

March 22, 1991

Acting NIH Director Says M.D. Anderson President John Mendelsohn Outlines 10-Point Plan For Cancer Research

February 20, 2009

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

Subgroup Agrees Five Compounds Are Carcinogens

January 20, 1978